Joshua G. Liang

机构：Clover Biopharmaceuticals (China)

发表论文 20 篇 · 总被引 820 次 · h-index 11

代表论文

• Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial (2021 · The Lancet · 被引 284)
• S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates (2021 · Nature Communications · 被引 163)
• Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial (2022 · The Lancet · 被引 113)
• Improvement of Pharmacokinetic Profile of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo (2017 · Scientific Reports · 被引 93)
• S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates (2020 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 26)
• A Broad Blockade of Signaling from the IL-20 Family of Cytokines Potently Attenuates Collagen-Induced Arthritis (2016 · The Journal of Immunology · 被引 25)